e-Learning About Cognitive Impairment and Dementia Prevention

August 17, 2023 updated by: McMaster University

Dementia Prevention Internet-Based Intervention: Randomized Controlled Trial and Knowledge Translation

In this proposal, the investigators plan to study the effectiveness of our web-based intervention on dementia prevention knowledge, intentions, and behaviour change. Participants will be randomized to one of two groups - intervention and control. Participants randomized to the intervention group will receive the dementia prevention e-learning. Participants in the control group will be assigned an alternate-topic e-learning lesson. All participants will be given access to all e-learning at the conclusion of the study.

The purpose of this phase is to explore if and how our dementia prevention e-learning influences participants' knowledge, intentions and health behaviours related to dementia risk.

Study Overview

Detailed Description

Background:

With our aging population, the prevalence of dementia is increasing dramatically. Developing a better understanding of how dementia can be prevented and sharing information about how Canadians can reduce their risk of developing dementia or delay its onset is critical to keeping Canadians healthy and improving quality of life. Web-based interventions in dementia have been shown to be effective for a range of outcomes, but very few have been widely implemented or rigorously studied; additionally, national, and provincial guidelines have all highlighted the importance of online resources to improve dementia prevention education. This has been further brought into focus by the coronavirus pandemic. While there have been studies of web-based health information on intentions and behaviour change, the vast majority of those studies have looked at text-based health information, rather than internet-based interventions that have incorporated best practices in instructional design for e-learning. This project will help to address this gap in the literature, as improved instructional design should have an impact on knowledge gain, which the investigators hypothesize may increase intentions and behaviour change.

The investigators developed a high-quality, award-winning web- and email-based dementia prevention education platform for care partners, which includes asynchronous, multimedia e-learning lessons and email-based 'micro-learning' content to reinforce the learning.

Objective:

In this proposal, the investigators plan to study the effectiveness of our web-based intervention on dementia prevention knowledge, intentions, and behaviour change.

Methods:

Design, Setting, and Participants:

This study is a sequential explanatory mixed methods design randomized controlled trial. Following eligibility screening, informed consent, and baseline socio-demographic measures, participants will be randomized either to the intervention group or the control group. Those adults (age ≥ 16) who have no prior diagnosis of dementia, have internet and email access, and are fluent in English will be eligible to participate. Participants will be randomized and directed to their assigned learning path after submitting online informed consent and baseline measures using the Division of e-Learning Innovation's research platform. Participants will be randomized using a block randomization. To the best of our ability, efforts will be made to blind participants to their allocation group and study hypotheses.

Intervention:

Participants randomized to the intervention group will receive the dementia prevention e-learning. Participants in the control group will be assigned an alternate-topic e-learning lesson. All participants will be given access to all e-learning at the conclusion of the study.

Outcomes:

The purpose of this phase is to explore if and how our dementia prevention e-learning influences participants' knowledge, intentions and health behaviours related to dementia risk.

The specific aims are:

  1. To evaluate whether exposure to the e-learning intervention changes knowledge of dementia risk factors, intention to engage in risk reduction activities, and health behaviours related to dementia prevention.
  2. To explore qualitative aspects such as participants' engagement and satisfaction with the intervention, as well as barriers and facilitators to use, through surveys and synchronous online focus groups.

Implications and Relevance:

The results of this study will contribute to the planning of a larger randomized controlled trial (RCT) in the future; as well as the evaluation of innovative, cost-effective, and efficient dementia prevention resources that can complement traditional approaches. The intervention could be easily scaled and spread to complement other dementia education methods.

Study Type

Interventional

Enrollment (Actual)

536

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8S 4L8
        • McMaster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • No prior diagnosis of dementia
  • Live in Canada
  • 16 years of age and over
  • Good command of the English language
  • Access to email and internet
  • Comfortable using email and internet, and
  • Ability to grant online informed consent

Exclusion Criteria:

  • Prior diagnosis of dementia
  • Lives outside of Canada
  • Not 16 years of age or over
  • Does not speak English,
  • Does not have access to email or internet
  • Is not comfortable using email of internet
  • Does not grant informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Education Intervention

Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components:

  1. One multimedia e-learning lesson on promoting brain health and preventing dementia;
  2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
  3. Curated resources related to dementia risk factors

Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components:

  1. One multimedia e-learning lesson on promoting brain health and preventing dementia;
  2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
  3. Curated resources related to dementia risk factors
Active Comparator: Education Control

Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components:

  1. One multimedia e-learning lesson on mild cognitive impairment;
  2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
  3. Curated resources related to mild cognitive impairment

Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components:

  1. One multimedia e-learning lesson on mild cognitive impairment;
  2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
  3. Curated resources related to mild cognitive impairment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge change (custom 15-item knowledge questionnaire related to key dementia prevention modifiable risk factors
Time Frame: 0 weeks, 4 weeks, 12 weeks
A custom 15-item knowledge questionnaire (multiple true-false response) to measure change related to key dementia prevention modifiable risk factors. Items are pulled from other validated surveys (i.e., Dementia Knowledge Assessment Scale) and key dementia prevention modifiable risk factors.
0 weeks, 4 weeks, 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intentions change (custom 10-item intentions questionnaire related to key dementia prevention modifiable risk factors)
Time Frame: 0 weeks, 4 weeks, 12 weeks

Intentions related to dementia prevention.

A custom 10-item intentions questionnaire (7 point Likert scale) to measure intentions to change related to key dementia prevention modifiable risk factors. Items were created based on key modifiable risk factors related to dementia as identified by the 2020 Lancet Commission Report.

0 weeks, 4 weeks, 12 weeks
Behaviour change
Time Frame: 0 weeks, 4 weeks, 12 weeks

Behaviour change related to dementia prevention.

A custom 42-item health behaviours questionnaire (Likert response options) to measure health behaviours related to key dementia prevention modifiable risk factors. Items are pulled from other validated surveys (Health and Behaviour Survey, Godin Leisure Time Exercise Questionnaire, World Health Organization for smoking status, etc.) and key dementia prevention modifiable risk factors.

0 weeks, 4 weeks, 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention adherence (time spent)
Time Frame: 4 weeks
Lesson completion data, email open rates, and resource downloads will be collected and saved to quantify the time(s) spent on intervention activities.
4 weeks
Participant satisfaction
Time Frame: 4 weeks
A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention.
4 weeks
Participant satisfaction
Time Frame: 4 weeks
A custom implementation oral interview questionnaire adapted from The Consolidated Framework for Implementation Research (CFIR) will be collected and saved to assess implementation of the intervention.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 27, 2023

Primary Completion (Actual)

August 3, 2023

Study Completion (Actual)

August 3, 2023

Study Registration Dates

First Submitted

May 5, 2022

First Submitted That Met QC Criteria

May 16, 2022

First Posted (Actual)

May 19, 2022

Study Record Updates

Last Update Posted (Actual)

August 21, 2023

Last Update Submitted That Met QC Criteria

August 17, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe